Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$2.25 - $7.4 $139,110 - $457,519
-61,827 Reduced 50.0%
61,827 $420,000
Q3 2023

Nov 02, 2023

BUY
$1.26 - $2.77 $155,804 - $342,521
123,654 New
123,654 $307,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $42.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Richmond Brothers, Inc. Portfolio

Follow Richmond Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richmond Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richmond Brothers, Inc. with notifications on news.